Anzeige
Mehr »
Mittwoch, 19.11.2025 - Börsentäglich über 12.000 News
Baltikum rüstet massiv auf: 500 Mio. Abwehrprogramm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W1LG | ISIN: IL0011224156 | Ticker-Symbol:
NASDAQ
19.11.25 | 18:43
0,710 US-Dollar
-1,76 % -0,013
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICECURE MEDICAL LTD Chart 1 Jahr
5-Tage-Chart
ICECURE MEDICAL LTD 5-Tage-Chart

Aktuelle News zur ICECURE MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:06IceCure Medical reports nine months ended results3
14:54IceCure Medical: IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 202544Momentum building in the U.S. and rising interest globally following landmark FDA marketing authorization for local cryoablation treatment of low-risk breast...
► Artikel lesen
DiWhat's Next: Icecure Medical's Earnings Preview1
DiIceCure Medical Ltd. - 6-K, Report of foreign issuer-
ICECURE MEDICAL Aktie jetzt für 0€ handeln
FrIceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification483CAESAREA, Israel, Nov. 14, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (the "Company"), developer of minimally-invasive cryoablation technology that...
► Artikel lesen
10.11.IceCure Medical: IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction80Mr. Levav's appointment ensures seamless and focused organizational structure as Company expands commercial activities in the U.S. following FDA marketing clearance for ProSense® CAESAREA...
► Artikel lesen
10.11.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
03.11.IceCure Medical: Positive Studienergebnisse zur Kryoablation lassen Aktie steigen3
03.11.IceCure Medical: IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival1335-year overall survival (OS) rate for stereotactic body radiation therapy (SBRT) followed by cryoablation was 74%, compared to published studies reporting 5-year OS of 41% - 52% with SBRT...
► Artikel lesen
03.11.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
17.10.IceCure Medical Ltd. - 6-K, Report of foreign issuer2
07.10.IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright3
06.10.ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment3
03.10.FDA approves IceCure cryoablation for breast cancer2
03.10.Icecure Medical: Aktie legt nach FDA-Zulassung für Brustkrebsbehandlung kräftig zu2
03.10.Icecure Medical stock surges after FDA approves breast cancer treatment1
03.10.IceCure Medical's ProSense Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive ...118ProSense ® cryoablation offers the choice of a minimally invasive outpatient procedure that destroys tumors by freezing without surgical removal of breast tissue First...
► Artikel lesen
30.09.IceCure Medical Ltd. - 6-K, Report of foreign issuer1
22.09.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
18.09.IceCure Wins Patent, Shares Stuck1
Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1